Media & Resources

The International AIDS Vaccine Initiative (IAVI) awards $875,000 in grants to two researchers identified through NineSigma’s Open Innovation process CLEVELAND, Ohio, February 21, 2012 – A collaboration between NineSigma and the International AIDS Vaccine Initiative (IAVI) is helping to advance HIV vaccine research by identifying new approaches to the design of a potential vaccine. A…

Accelerate Development of Vaccines against Major Global Diseases NEW YORK –The International AIDS Vaccine Initiative (IAVI) has received a $378,000 grant from the Robert Wood Johnson Foundation to convene international scientists and public-health experts to explore the creation of a Human Vaccines Project that could collectively leverage technological advances to accelerate the development of new…

NEW YORK – The International AIDS Vaccine Initiative (IAVI) is pleased to announce that Dr. Alex Godwin Coutinho has taken over the role of Chair of its Board of Directors, and U.S. Ambassador Eric Goosby and the Rt. Hon. the Lord Fowler have become new members of the Board. Dr. Coutinho is a driving force…

IAVI joins the world in mourning the passing of Nelson Mandela, in celebrating his life, and in renewing our commitment to honor his legacy. As we work toward a vaccine that will help to end AIDS, we stand proudly among the many individuals and organizations who are guided by Mandela’s vision of a global future…

On this World AIDS Day, the International AIDS Vaccine Initiative (IAVI) pays tribute to the tens of millions of people who have lost their lives by reaffirming our commitment to finding a vaccine that will help end the AIDS pandemic. “There has been tremendous success in treating millions with HIV over the past three decades,”…

NEW YORK – The International AIDS Vaccine Initiative (IAVI) congratulates the researchers from The Scripps Research Institute (TSRI) and Cornell University for their landmark findings published in Science, describing the structure of the outer part of the HIV trimer, the tripartite HIV Envelope protein. IAVI is proud to have supported this research together with the National…

HIV-AIDS: much accomplished, much to do Achieving an AIDS-free World: Science and Implementation NEW YORK – The International AIDS Vaccine Initiative (IAVI) welcomes the reaffirmation of the “paramount” importance of a vaccine to ending the AIDS pandemic, and the realistic appraisal of the challenges to achieving this imperative, as outlined by Anthony S. Fauci and his…

UPDATE: NEW YORK, NY; September 23, 2013. Vaccinations for a Phase I trial for the novel SeV-G vaccine candidate began this month at the St. Stephen’s Centre in London, the third and final location. The trial began earlier this year at Projet San Francisco in Kigali, Rwanda, and at the Kenya AIDS Vaccine Initiative in Nairobi.…